2014
DOI: 10.4161/15384047.2014.987021
|View full text |Cite
|
Sign up to set email alerts
|

AMPK/mTOR-mediated inhibition of survivin partly contributes to metformin-induced apoptosis in human gastric cancer cell

Abstract: Recent studies demonstrated that metformin exerts anti-neoplastic effect in a spectrum of malignancies. However, the mechanism whereby metformin affects various cancers, including gastric cancer, is poorly elucidated. Considering apoptosis plays critical role in tumorigenesis, we, in the present study, investigated the in vitro apoptotic effect of metformin on human gastric cancer cell and the underlying mechanism. Three differently-differentiated gastric cancer cell lines, MKN-28, SGC-7901 and BGC-823, along … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
64
0
1

Year Published

2015
2015
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 91 publications
(68 citation statements)
references
References 34 publications
3
64
0
1
Order By: Relevance
“…Since metformin is known to affect AMPK/mTOR signaling activity [32], we compared the effects of MFB and metformin in this regard. Various breast cancer cell lines (luminal type, MCF7 and BT474; TNBC type, BT20, MDA-MB-231, Hs578T and NDY-1) were treated with metformin or MFB (10 mM) for 12 h, and cell lysates were analyzed for their levels of p-AMPK (T172) and p-mTOR (S2448).…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Since metformin is known to affect AMPK/mTOR signaling activity [32], we compared the effects of MFB and metformin in this regard. Various breast cancer cell lines (luminal type, MCF7 and BT474; TNBC type, BT20, MDA-MB-231, Hs578T and NDY-1) were treated with metformin or MFB (10 mM) for 12 h, and cell lysates were analyzed for their levels of p-AMPK (T172) and p-mTOR (S2448).…”
Section: Resultsmentioning
confidence: 99%
“…Metformin is known to inactivate mTOR via activation of AMPK, thereby directly inhibiting cell growth and tumorigenesis [9, 31]. Although the precise underlying mechanism(s) have not yet been fully elucidated, increasing evidence indicates that the P13K/Akt/mTOR pathway plays a crucial role in the survival and proliferation of cancer cells [9, 11, 15, 32, 35]. Therefore, it is clinically important that, compared to metformin, MFB markedly activated AMPK and inactivated mTOR with greater potency in all tested breast cancer cells in vitro and in vivo .…”
Section: Discussionmentioning
confidence: 99%
“…Silvestri et al [36] reported that metformin induced apoptosis and down-regulated PKM2 in breast cancer cells. These studies showed that the mechanism of metformin may be associated with the following observations: (1) metformin inhibits mTOR activation by AMPK-dependence in different cancers [37,38,39]; (2) mTOR signaling regulates P70S6K signaling in cervical carcinoma cells [40]; (3) metformin induce intrinsic apoptosis via the inhibition of the HIF1α/PKM2 signaling pathway [41]; and (4) metformin is also a poisoner of mitochondria by impairing the function of complex I [42], leading to the increased aerobic glycolysis as compensation.…”
Section: Discussionmentioning
confidence: 99%
“…Previous studies reported that metformin downregulated mTOR signaling by activating AMPK in various tumors [31][32][33]. To examine whether this machinery worked in OS cells and CSCs, we carried out Western blotting.…”
Section: Ampk/mtor/s6 Pathway Following Metformin Treatment In Os Celmentioning
confidence: 99%